These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
19 related articles for article (PubMed ID: 1221434)
1. Stress-induced partial insomnia: a model for the evaluation of potential hypnotic compounds [proceedings]. Piper DC Br J Pharmacol; 1977 Mar; 59(3):509P. PubMed ID: 557356 [No Abstract] [Full Text] [Related]
2. Intrathecal chlorprothixene, cis(z)-flupenthixol, chlorpromazine and fluphenazine for prolonged spinal blockades of sensory and motor functions in rats. Chen YW; Chu CC; Chen YC; Leung YM; Wang JJ Eur J Pharmacol; 2012 Oct; 693(1-3):31-6. PubMed ID: 22926199 [TBL] [Abstract][Full Text] [Related]
3. Behavioral and electroencephalographic effects of a depot type neuroleptic fluphenazine decanoate, in rats. Yamamoto T; Ueki S J Pharmacobiodyn; 1989 Nov; 12(11):681-92. PubMed ID: 2632765 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological vs. clinical physiognomy of neuroleptics, with special reference to their sedative and antipsychotic effects. Nielsen IM Acta Psychiatr Belg; 1974 Sep; 74(5):473-84. PubMed ID: 4471027 [No Abstract] [Full Text] [Related]
5. Comparison of T-wave changes in the dog following intravenous administration of chlorpromazine and fluphenazine. Hassert GL; Peterson AE; Burke JC Nature; 1965 Aug; 207(998):765-6. PubMed ID: 5885925 [No Abstract] [Full Text] [Related]
6. Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? IV. An improved experimental design for measuring the inhibitory effects of neuroleptic drugs on amphetamine-or apomorphine-induced "Cheroing" and "agitation" in rats. Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM Arzneimittelforschung; 1967 Jul; 17(7):841-54. PubMed ID: 5632842 [No Abstract] [Full Text] [Related]
7. Relationship between the behavioral and electroencephalographic effects of chlorpromazine and fluphenazine in rats. Babbini M; Gaiardi M; Bartoletti M Pharmacology; 1975; 13(6):520-5. PubMed ID: 1221434 [TBL] [Abstract][Full Text] [Related]
8. Behavioral consequences of long-term treatment with neuroleptic drugs. Iversen SD; Howells RB; Hughes RP Adv Biochem Psychopharmacol; 1980; 24():305-13. PubMed ID: 6105782 [No Abstract] [Full Text] [Related]
9. Evidence for involvement of dopamine in the action of diazepam: potentiation of haloperidol and chlorpromazine action in the brain. Rastogi RB; Lapierre YD; Singhal RL; Nair NP Adv Biochem Psychopharmacol; 1980; 24():283-9. PubMed ID: 6996443 [No Abstract] [Full Text] [Related]